Back
Apellis Pharmaceuticals Stock Price Chart
Sponsored
APLS
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
APLS
Apellis Pharmaceuticals
Last Price:
36.70
Seasonality Move:
15.53%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
Apellis Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.02 | Sell |
20-day SMA: | 38.38 | Sell |
50-day SMA: | 38.01 | Sell |
200-day SMA: | 50.16 | Sell |
8-day EMA: | 36.95 | Sell |
20-day EMA: | 37.71 | Sell |
50-day EMA: | 38.48 | Sell |
200-day EMA: | 45.83 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 45.36 | Sell |
Chaikin Money Flow: | -475428 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.98 - 39.8) | Sell |
Bollinger Bands (100): | (36.68 - 42.54) | Sell |
Apellis Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 36.73 while APLS 8-day simple moving average is 37.02, which is a Sell signal.
- The stock price of APLS is 36.73 while Apellis Pharmaceuticals 20-day SMA is 38.38, which makes it a Sell.
- Apellis Pharmaceuticals 50-day simple moving average is 38.01 while APLS share price is 36.73, making it a Sell technically.
- APLS stock price is 36.73 and Apellis Pharmaceuticals 200-day simple moving average is 50.16, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
25
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Sell
The current Apellis Pharmaceuticals [APLS] share price is $36.73. The Score for APLS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
4.47B
Price in USD:
36.73
Share Volume:
1.74M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
33.49
Sell
25
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 36.73 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 36.73 while APLS 8-day exponential moving average is 36.95, which is a Sell signal.
- The stock price of APLS is 36.73 while Apellis Pharmaceuticals 20-day EMA is 37.71, which makes it a Sell.
- Apellis Pharmaceuticals 50-day exponential moving average is 38.48 while APLS share price is 36.73, making it a Sell technically.
- APLS stock price is 36.73 and Apellis Pharmaceuticals 200-day simple moving average is 45.83, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is -0.49, suggesting Apellis Pharmaceuticals is a Sell
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 45.36, which suggest Apellis Pharmaceuticals is oversold
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (36.98 - 39.8), which suggest Apellis Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (36.68 - 42.54), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.